Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer.

MLA

Marrett, Elizabeth, et al. “Factors Associated with Time to EGFR TKI Treatment in Patients with Non-Squamous Metastatic Non-Small-Cell Lung Cancer.” Future Oncology, vol. 18, no. 13, May 2022, pp. 1535–44. EBSCOhost, https://doi.org/10.2217/fon-2021-1452.

APA

Marrett, E., Kwong, W. J., & Chow, L. Q. (2022). Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer. Future Oncology, 18(13), 1535–1544. https://doi.org/10.2217/fon-2021-1452

Chicago

Marrett, Elizabeth, Winghan Jacqueline Kwong, and Laura QM Chow. 2022. “Factors Associated with Time to EGFR TKI Treatment in Patients with Non-Squamous Metastatic Non-Small-Cell Lung Cancer.” Future Oncology 18 (13): 1535–44. doi:10.2217/fon-2021-1452.